BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9645799)

  • 21. Rapid rejection of HLA-A2 transgenic skin graft due to indirect allorecognition.
    Jurcevic S; Chandler P; Sacks SH; Simpson E
    Transplantation; 2001 Sep; 72(6):994-7. PubMed ID: 11579290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exhaustive differentiation of alloreactive CD8+ T cells: critical for determination of graft acceptance or rejection.
    Steger U; Denecke C; Sawitzki B; Karim M; Jones ND; Wood KJ
    Transplantation; 2008 May; 85(9):1339-47. PubMed ID: 18475193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
    Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R
    Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL; Zadach K; Nalesnik M; Ildstad ST
    Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice.
    Valujskikh A; Matesic D; Gilliam A; Anthony D; Haqqi TM; Heeger PS
    J Clin Invest; 1998 Mar; 101(6):1398-407. PubMed ID: 9502782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relative contribution of direct and indirect antigen recognition pathways to the alloresponse and graft rejection depends upon the nature of the transplant.
    Illigens BM; Yamada A; Fedoseyeva EV; Anosova N; Boisgerault F; Valujskikh A; Heeger PS; Sayegh MH; Boehm B; Benichou G
    Hum Immunol; 2002 Oct; 63(10):912-25. PubMed ID: 12368044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.
    Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP
    J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice.
    Auchincloss H; Lee R; Shea S; Markowitz JS; Grusby MJ; Glimcher LH
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3373-7. PubMed ID: 8475083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rejection of cultured keratinocyte allografts in presensitized mice.
    Kawai K; Ikarashi Y; Tomiyama K; Matsumoto Y; Fujiwara M
    Transplantation; 1993 Aug; 56(2):265-9. PubMed ID: 8356578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphocytes selected in allogeneic thymic epithelium mediate dominant tolerance toward tissue grafts of the thymic epithelium haplotype.
    Modigliani Y; Thomas-Vaslin V; Bandeira A; Coltey M; Le Douarin NM; Coutinho A; Salaün J
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7555-9. PubMed ID: 7638230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed allogeneic skin graft rejection in CD26-deficient mice.
    Zhao X; Zhang K; Daniel P; Wisbrun N; Fuchs H; Fan H
    Cell Mol Immunol; 2019 Jun; 16(6):557-567. PubMed ID: 29572550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD8+ T lymphocytes account for acute accelerated allograft rejection in the rag mouse model.
    Yoshimura R; Wada S; Nakatani T; Tsujino T; Yamamoto K; Kishimoto T; Ohyama A; Chargui J; Touraine JL
    Transplant Proc; 1998 Nov; 30(7):2952. PubMed ID: 9838301
    [No Abstract]   [Full Text] [Related]  

  • 33. CD8
    Du G; Yang N; Gong W; Fang Y; He J; Zhou N; Lu X; Zhao Y
    Exp Cell Res; 2017 Jun; 355(1):1-8. PubMed ID: 28232114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of immune response to nerve and skin allografts.
    Trumble T; Gunlikson R; Parvin D
    J Reconstr Microsurg; 1993 Sep; 9(5):367-72. PubMed ID: 8301635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral blood leukocyte grafts that induce human to mouse graft-vs.-host disease reject allogeneic human skin grafts.
    Huppes W; Hoffmann-Fezer G
    Am J Pathol; 1995 Dec; 147(6):1708-14. PubMed ID: 7495295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro production and transplantation of immunologically active skin equivalents.
    Rouabhia M
    Lab Invest; 1996 Oct; 75(4):503-17. PubMed ID: 8874382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reepithelialized orthotopic tracheal allografts expand memory cytotoxic T lymphocytes but show no evidence of chronic rejection.
    Cleven HA; Genden EM; Moran TM
    Transplantation; 2005 Apr; 79(8):861-8. PubMed ID: 15849536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skin graft rejection elicited by beta 2-microglobulin as a minor transplantation antigen involves multiple effector pathways: role of Fas-Fas ligand interactions and Th2-dependent graft eosinophil infiltrates.
    Surquin M; Le Moine A; Flamand V; Nagy N; Rombaut K; Demoor FX; Stordeur P; Salmon I; Guéry JC; Goldman M; Abramowicz D
    J Immunol; 2002 Jul; 169(1):500-6. PubMed ID: 12077281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viral abrogation of stem cell transplantation tolerance causes graft rejection and host death by different mechanisms.
    Forman D; Welsh RM; Markees TG; Woda BA; Mordes JP; Rossini AA; Greiner DL
    J Immunol; 2002 Jun; 168(12):6047-56. PubMed ID: 12055213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of localized cytokine dysregulation: accelerated rejection of IL-2-expressing skin grafts.
    Blackburn C; Grogan JL; Augustine CL; Miller JF; Varigos G; Morahan G
    Immunol Cell Biol; 2001 Apr; 79(2):128-31. PubMed ID: 11264705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.